TheEdgeResearch
Home / Stocks / GLASF

Glass House Brands Inc. (GLASF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$10.79 ▼ -8.64%
Market Cap
$851.8M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.51
52-Wk Range
4.55-13.93
CEO
Kyle D. Kazan
Country
US
Currency
USD

Glass House Brands Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Long Beach, CA, US. The stock last traded at $10.79, down 8.64% on the session, giving a market capitalisation of $851.8M. Its beta of 0.51 implies it has historically moved less than the broad market.

Company profile
Exchange
Other OTC
Employees
321
IPO date
2019-07-18
Headquarters
Long Beach, CA, US
About Glass House Brands Inc.

Headquartered in Long Beach, California, Glass House Brands Inc. is a vertically integrated cannabis company. Established in 2015, it manages the cultivation, production, sale, and distribution of raw cannabis, cannabis oil, and various consumer cannabis products. The company supplies its offerings to both wholesale partners and retail stores, marketing its cannabis goods under popular labels such as Glass House Farms, Forbidden Flowers, and Mama Sue.

Comparable companies

Glass House Brands Inc. is most often compared with the following Healthcare names:

AGYTFBOIRFCRLBFELTPHUMDFJCRRFKHTRFLBLTFMNFSFVRNOF
More research on GLASF
GLASF technical analysis GLASF TheEdge Score Compare against peers
Open full interactive analysis & DCF →